跳至主要内容
临床试验/CTRI/2014/10/005139
CTRI/2014/10/005139已完成4 期

Comparative efficacy of metformin, pioglitazone and rosuvastatin on metabolic profile in patients with metabolic syndrome.

Department of Pharmacology0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with 18-60 years of age and either sex diagnosed with Metabolic Syndrome. Conformation to written informed consent.

排除标准

  • Patient not willing to give informed consent, type I diabetes mellitus, type II diabetes mellitus(fasting plasma glucose of >126mg/dl), severely deranged lipid profile(TG >500 mg/dl, LDLC >250mg /dl), liver enzymes >2 times of upper limit and serum creatinine >2mg/dl, history of heart disease, familial dyslipidemia, hyper or
  • hypothyroidism, major medical/surgical illness, hypersensitivity to any of the used drugs, pregnant and lactating females, patient on any other long term concomitant drugs known to affect
  • glucose tolerance or lipid profile

研究者

相似试验